Esmolol Shows Promise in Reducing Mortality in Septic Shock Patients
In adults with septic shock, esmolol may be the most effective beta blocker for reducing mortality and improving clinical outcomes, compared with landiolol or...
SGLT2 Inhibitors May Slow the Growth of Early-Stage Lung Cancers
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of FDA-approved antidiabetic medications, may slow the growth of early-stage lung cancer and help patients with in...
Ensifentrine Improves the Lives of COPD Patients Without Exacerbations
People with COPD suffer from daily symptoms and impaired quality of life, and COPD treatments to address these burdens are needed. Ensifentrine, a novel...
Nerandomilast Slows Idiopathic Pulmonary Fibrosis Progression in US Patients
Among patients in the United States who receive standard-of-care therapy for idiopathic pulmonary fibrosis, adding nerandomilast slows disease progression. In the US subgroup of...